NSE - Delayed Quote INR
Syncom Formulations (India) Limited (SYNCOMF.NS)
17.04
-0.93
(-5.18%)
At close: April 25 at 3:30:00 PM GMT+5:30
Breakdown
TTM
3/31/2024
3/31/2023
3/31/2022
3/31/2021
Operating Cash Flow
113,058.36
-59,583
105,293
163,290
-20,631
Investing Cash Flow
-84,784.80
830,196
-449,527
-270,733
-753,533
Financing Cash Flow
-905.52
-145,576
350,014
82,945
719,604
End Cash Position
88,811.04
633,834
8,797
3,017
27,514
Capital Expenditure
-18,571.76
-81,364
-206,347
-113,129
-26,557
Issuance of Capital Stock
--
--
145,788
136,302
121,060
Free Cash Flow
94,486.59
-140,947
-101,054
50,161
-47,188
3/31/2021 - 11/18/2022
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
LASA.BO Lasa Supergenerics Limited
17.20
-3.91%
SIGACHI.NS Sigachi Industries Limited
42.84
-5.72%
LASA.NS Lasa Supergenerics Limited
17.22
-3.53%
THEMISMED.NS Themis Medicare Limited
133.54
-3.60%
BALPHARMA.NS Bal Pharma Limited
107.14
-1.61%
SHUKRAPHAR.BO Shukra Pharmaceuticals Limited
17.22
-4.97%
GENNEX.BO Gennex Laboratories Limited
13.24
-4.20%
NECLIFE.BO Nectar Lifesciences Limited
22.79
-4.68%
RPGLIFE.NS RPG Life Sciences Limited
2,244.30
-3.82%
ORCHPHARMA.NS Orchid Pharma Limited
808.55
-4.14%